Metabolic side effects of antipsychotics: focus on hyperglycemia and diabetes.

作者: John B. Buse

DOI:

关键词:

摘要: Approximately 16 million people in the United States have diabetes, and World Health Organization has estimated that worldwide prevalence of diabetes will more than double from 1995 to 2025. Type 2 most common form may be 4 times prevalent patients with severe mental disorders. Within psychiatric community, there is a great deal concern about as potential side effect antipsychotic agents. An important population remember context treatment-emergent hyperglycemia 20 impaired glucose tolerance (IGT) (fasting plasma > 110 mg/dL 140 < 200 according American Diabetes Association). This prediabetic condition 5% 10% annual risk converting diabetes. One hypothesis for during double-blind, randomized, controlled trials who develop soon after initiation drug therapy schizophrenia had undiagnosed IGT or before they started treatment. The emergence clinical practice due an observation effect, but because incidence greater illnesses, it crucial psychiatrists aware national guidelines diagnosis treatment type

参考文章(12)
Shalom Coodin, Body mass index in persons with schizophrenia. The Canadian Journal of Psychiatry. ,vol. 46, pp. 549- 555 ,(2001) , 10.1177/070674370104600610
Pauline Camacho, Shailesh Pitale, Carlos Abraira, Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus. Drugs & Aging. ,vol. 17, pp. 463- 476 ,(2000) , 10.2165/00002512-200017060-00004
L. Dixon, P. Weiden, J. Delahanty, R. Goldberg, L. Postrado, A. Lucksted, A. Lehman, Prevalence and Correlates of Diabetes in National Schizophrenia Samples Schizophrenia Bulletin. ,vol. 26, pp. 903- 912 ,(2000) , 10.1093/OXFORDJOURNALS.SCHBUL.A033504
K. Kwong, K. Hornbuckle, W. Signa, P. Cavazzoni, D. Hutchins, Higher incidences of diabetes mellitus during exposure to antipsychotics — findings from a retrospective cohort study in the US European Neuropsychopharmacology. ,vol. 11, ,(2001) , 10.1016/S0924-977X(01)80357-6
Ali H Mokdad, Earl S Ford, Barbara A Bowman, David E Nelson, Michael M Engelgau, Frank Vinicor, James S Marks, None, The Continuing Increase of Diabetes in the U.S. Diabetes Care. ,vol. 24, pp. 412- 412 ,(2001) , 10.2337/DIACARE.24.2.412
R J Rubin, W M Altman, D N Mendelson, Health care expenditures for people with diabetes mellitus, 1992. The Journal of Clinical Endocrinology & Metabolism. ,vol. 78, pp. 809A- 809F ,(1994) , 10.1210/JCEM.78.4.8157701
Ali H Mokdad, Earl S Ford, Barbara A Bowman, David E Nelson, Michael M Engelgau, Frank Vinicor, James S Marks, None, Diabetes trends in the U.S.: 1990-1998. Diabetes Care. ,vol. 23, pp. 1278- 1283 ,(2000) , 10.2337/DIACARE.23.9.1278
Eileen Ahearn, Frederick Cassidy, Bernard J. Carroll, Elevated Frequency of Diabetes Mellitus in Hospitalized Manic-Depressive Patients American Journal of Psychiatry. ,vol. 156, pp. 1417- 1420 ,(1999) , 10.1176/AJP.156.9.1417
Sukdeb Mukherjee, Paolo Decina, Vittorio Bocola, Fernando Saraceni, PierLuigi Scapicchio, Diabetes mellitus in schizophrenic patients Comprehensive Psychiatry. ,vol. 37, pp. 68- 73 ,(1996) , 10.1016/S0010-440X(96)90054-1